NASDAQ:ATAI
Shares of AtaiBeckley Inc. remained flat at $7.17 as of 1 p.m. on Tuesday. This price stood 42 cents higher than Eli Lilly and Co.'s $6.75 cash offer at close.
Company hubNASDAQ:ATAI
Follow the latest AtaiBeckley (ATAI) company news, earnings coverage and investor analysis from TechStock².
All coverage
Shares of AtaiBeckley Inc. finished Monday at $7.19, standing 44 cents above the cash bid from Eli Lilly and Co.. Reporting occurred after Nasdaq’s…
AtaiBeckley, previously known as Atai Life Sciences, closed at $7.22 on Friday, trading 47 cents higher than the cash element of Eli Lilly’s offer.…
AtaiBeckley Inc. was priced at $7.091 ahead of Friday’s session, declining 0.8%. The share price remained 34 cents higher than Eli Lilly and Co.’s…
NEW YORK, July 16, 2026, 5:08 p.m. EDT – Shares of Eli Lilly edged higher on Thursday after the drugmaker announced a deal with…
AtaiBeckley Inc. jumped about 31% to $7.04 on Thursday. Eli Lilly and Co. agreed to buy the company for up to $3.8 billion.
AtaiBeckley Inc. shares climbed 15.6% to about $5.75 in Tuesday afternoon trading as investors weighed final U.S. Food and Drug Administration guidance for psychedelic-drug…
AtaiBeckley Inc. jumped 7.8% to $4.14 on Tuesday. Chief Executive Srinivas Rao said the company’s lead depression drug, BPL-003, advanced into Phase 3 trials.…
Atai shares exploded higher on Oct. 17, 2025. Investors bid the stock up ~17.7%, closing at roughly $6.45 ts2.tech. In after-hours trading it briefly…
ATAI’s stock price surged in the last few days amid a flurry of good news. Shares jumped 17.7% on Friday alone, finishing at $6.45marketbeat.com,…
